MGI and Bio-Medical Science Partner to Provide Advanced Sequencing Solutions to South Korea

14 September 2023 | Thursday | News


MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions in South Korea by leveraging MGI's cutting-edge technology. The MOU is expected to reach collaborations in localizing MGI's manufacturing capability in selected genetic sequencers and reagents in South Korea via BMS, which will provide the market with state-of-the-art products that have been adapted to local needs, thereby helping advance genomic research and clinical diagnostics.
Image Source : Public Domain

Image Source : Public Domain

"This MOU marks a key milestone for the development of genomics in South Korea as we introduce localized, high-quality and cost-effective solutions powered by our proprietary DNBSEQ™ technology." said Roy Tan, General Manager of MGI Asia Pacific. "By joining forces with our partner BMS, MGI aims to facilitate more widespread adoption of genomics, multi-omics, metagenomics and related business locally in South Korea." 

Under the MOU, BMS and MGI will work to reach collaborations relating to the licensing, supply, manufacturing and distribution of selected genetic sequencers and reagents in South Korea. Leveraging BMS' strong local network for sales and distribution and MGI's innovative technology, South Korea is set to further tap into the potential of larger scale genomics, clinical studies and even microbiome.

"Amidst a rapidly growing high-throughput sequencing market in South Korea, we are noticing a mismatch between demand and supply and hope to eliminate access barriers by bringing products and solutions that are proven efficient, convenient and suited for local needs," said Kangsan D. Kim, Director of Marketing & Communications at BMS. "We are excited to partner with MGI to speed up the localization of their cutting-edge genomics products, especially sequencers such as DNBSEQ-G99."

In fact, the relationship between MGI and BMS can be traced back to 2019, when BMS became the first company in Asia Pacific to join MGI's Global Sequencer User Program (SUP) to promote the development of genetic technologies and applications through customized products and services. Earlier this year, the two companies also partnered to establish a joint Customer Experience Center (CEC) in South Korea, aiming to provide local customers with first-hand access to MGI's newer technologies and products.

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close